Join PADT and Thermo Fisher Scientific's Steven Kjar for a presentation on the use of additive manufacturing in the development process for pharmaceutical equipment. Historically additive manufacturing has had a limited role within companies who supply to the biopharmaceutical industry due to the industry’s requirements on materials and practices. Stainless steel components are typically used and switching over to the implementation of plastic-based materials used in additive manufacturing was a major undertaking. Not only do the advanced manufacturing process capabilities of Stratasys 3D printers make for a worthy solution, the company also produces a variety of composite materials that can operate within a bioreactor due to their unique characteristics. Register now to learn more about this incredibly unique application. About Steven Kjar: Steven has attended many colleges and universities while developing skills, including Snow College, Brigham Young University, Utah State University, University of Washington, and Penn State. After a long search for the perfect career, he found his passion in mechanical engineering with a focus on 3D printing. Steven currently working at Thermo Fisher Scientific as a mechanical engineer in R&D. As part of his responsibilities he has been entrusted with the development of an additive manufacturing program for Thermo Fisher in Logan, Utah, and has spent six years building a 3D printing lab that is now capable of producing ISO13485 compliant parts. Steven wants to move to the next challenge of producing additively manufactured parts for end use; parts produced to reduce cost, serve a custom purpose, or to make life better for others.